newsfilter
← Latest News
GlobeNewswire·

Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate

Product is currently under review with the FDAPotential approval and launch mid-2026 DEER PARK, Ill., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc ("Eton" or "the Company") (NASDAQ:ETON), an innovative